Dow Jones shareholder sees $60 bid attractive: FT

(Reuters) - "The offer to purchase Dow Jones at $60 in our view represents a fairly attractive transaction price. I find it hard to believe the company itself has a plan to get the shares to $60," the Financial Times quoted Brian Rogers, the chairman and chief investment officer of T. Rowe Price saying. The firm holds about 15 percent of Dow Jones according to Reuters data.




A spokesman for T. Rowe told Reuters: "We've said all along that as long-term investors in Dow Jones stock we're gratified that other investors have recognized the value that we always thought was there. We think it is a reasonable offer to take under consideration."


Read more at Reuters.com Business News

Motorola says to cut 4,000 more jobs

(Reuters) - The company had earlier said it would cut 3,500 jobs by
June 30.







Read more at Reuters.com Business News

UBS names Los Angeles investment bank office heads

(Reuters) - Stewart and Joliet succeed Jeff Raich, the bank's global
M&A co-head who announced his resignation on Friday after six
years. Raich is the latest top investment banker to leave the
Swiss bank's dealmaking ranks over the past 2-1/2 months.




UBS investment bank President Ken Moelis, also based in Los
Angeles, and former investment bank co-head Jeff McDermott
quit, both quit in March, fueling speculation that other
departures would follow amid concern the bank was reluctant to
finance some leveraged buyouts.


Read more at Reuters.com Mergers News

TiVo posts quarterly profit

(Reuters) - Analysts had expected a loss of 2 cents a share, according
to Reuters Estimates.




Read more at Reuters.com Market News

Joy Global, Pennsylvania REIT, Biogen, NiSource: U.S. Equity Movers Final

(Bloomberg) -- The following is a list of companies
whose shares had unusual price changes in U.S. exchanges today.
Stock symbols are in parentheses after company names. Shares
prices are as of 4 p.m. New York time.

Biogen Idec Inc. (BIIB US) rose $2.92, or 5.9 percent, to
$52.13. The maker of the multiple sclerosis drug Tysabri began
accepting bids in a buyback of as much as $3 billion in shares.
The buyback, which will give Biogen an additional 16 percent of
its 342.6 million shares outstanding, will be funded by cash and
borrowings, Biogen said. The company will pay stockholders
between $47 and $53 a share in the so-called Dutch Auction.


Read more at Bloomberg Stocks News

AES acquires two U.S. wind power projects from GE

(Reuters) - AES plans to triple its wind capacity in the next four
years by adding about 2,100 MW of new wind generation capacity
worldwide by 2011. It has more than 1,000 MW of wind facilities
in operation or under construction in the United States.




Ned Hall, head of AES's renewable generation operations,
said about two-thirds of the planned expansion would be in the
United States.


Read more at Reuters.com Mergers News

Utilities propose $500 mln Ill. power rate relief

(Reuters) - Both companies indicated they would participate in such a
proposal, the terms of which are open to negotiation, as long
as the General Assembly does not pass rate freeze, generation
tax or other adverse legislation.




Under the proposal, ComEd would give $200 million in power
rate reductions to residential consumers during the summer
months of 2007 and 2008 to help ease the transition from capped
electricity rates to market based rates.


Read more at Reuters.com Government Filings News